聚合搜Scholar - 壹搜网为您找到"

pytorch分类

"相关结果 10条

Deep learning-based identification of aberrant anterior tibial artery on knee MRI: a brazilian multicenter study.

To develop and validate a deep learning model for the detection of aberrant anterior tibial artery (AATA) on axial T2-weighted knee MRI, given the surgical relevance of unrecognized AATA and the lack of automated detection tools.
www.ncbi.nlm.nih.gov

Two-step deep-learning candidemia prediction model using two large time-sequence electronic health datasets.

Candidemia is a rare but life-threatening bloodstream infection that remains difficult to predict using conventional risk stratification approaches, highlighting the need for improved predictive strategies. As a result, empiric antifungal therapy is often delayed even in high-risk patients.
www.ncbi.nlm.nih.gov

Deep learning-based upsampling of 2D detector array measurements for patient plan verification in radiotherapy.

Detector arrays are commonly used for treatment plan verifications in intensity modulated radiation therapy. However, the intrinsic resolution of detector arrays is limited by the physical dimensions of each single detector and the detector-to-detector distance. This may lead to inaccurate representations of steep gradients and narrow dose peaks.
www.ncbi.nlm.nih.gov

Optimizing Selective RF Pulses for Enhanced Signal Stability in Turbo Spin Echo Using a Differentiable Extended Phase Graph Model.

To improve slice profile consistency across echo trains in turbo spin echo (TSE) imaging, thereby reducing image blurring and increasing the accuracy of multi echo spin echo
www.ncbi.nlm.nih.gov

[Construction of a prognosis forecasting model for immuno-therapy response in cancer patients by integrating routine clinical parameters and tumor mutational burden].

To develop a machine-learning model that integrates routine clinical parameters with tumor mutational burden (TMB) and to evaluate its performance in predicting responses to programmed death-1 (PD-1)/programmed death-ligand 1(PD-L1) inhibitors across various cancer types.
www.ncbi.nlm.nih.gov